BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33434687)

  • 1. Ras related GTP binding D promotes aerobic glycolysis of hepatocellular carcinoma.
    Ding L; Liang X
    Ann Hepatol; 2021; 23():100307. PubMed ID: 33434687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma.
    Weng Q; Chen M; Yang W; Li J; Fan K; Xu M; Weng W; Lv X; Fang S; Zheng L; Song J; Zhao Z; Fan X; Ji J
    FASEB J; 2020 Apr; 34(4):5420-5434. PubMed ID: 32080912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma.
    Lu C; Fang S; Weng Q; Lv X; Meng M; Zhu J; Zheng L; Hu Y; Gao Y; Wu X; Mao J; Tang B; Zhao Z; Huang L; Ji J
    Cell Commun Signal; 2020 Jun; 18(1):97. PubMed ID: 32576292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-dependent expression of MAP17 coordinates the Warburg effect to tumor growth in hepatocellular carcinoma.
    Dong F; Li R; Wang J; Zhang Y; Yao J; Jiang SH; Hu X; Feng M; Bao Z
    J Exp Clin Cancer Res; 2021 Apr; 40(1):121. PubMed ID: 33832535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.
    Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D
    Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.
    Hua S; Lei L; Deng L; Weng X; Liu C; Qi X; Wang S; Zhang D; Zou X; Cao C; Liu L; Wu D
    Oncogene; 2018 Mar; 37(12):1624-1636. PubMed ID: 29335523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.
    Zhou Y; Lin F; Wan T; Chen A; Wang H; Jiang B; Zhao W; Liao S; Wang S; Li G; Xu Z; Wang J; Zhang J; Ma H; Lin D; Li Q
    Theranostics; 2021; 11(12):5926-5938. PubMed ID: 33897890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTOR regulates aerobic glycolysis through NEAT1 and nuclear paraspeckle-mediated mechanism in hepatocellular carcinoma.
    Zhang H; Su X; Burley SK; Zheng XFS
    Theranostics; 2022; 12(7):3518-3533. PubMed ID: 35547764
    [No Abstract]   [Full Text] [Related]  

  • 9. MiR-20b-5p promotes hepatocellular carcinoma cell proliferation, migration and invasion by down-regulating CPEB3.
    Li Z; Wu L; Tan W; Zhang K; Lin Q; Zhu J; Tu C; Lv X; Jiang C
    Ann Hepatol; 2021; 23():100345. PubMed ID: 33812045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA hsa_circ_0091579 facilitates the Warburg effect and malignancy of hepatocellular carcinoma cells via the miR-624/H3F3B axis.
    Chen Y; Song S; Zhang L; Zhang Y
    Clin Transl Oncol; 2021 Nov; 23(11):2280-2292. PubMed ID: 33934291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression.
    Cheng Q; Yuan F; Lu F; Zhang B; Chen T; Chen X; Cheng Y; Li N; Ma L; Tong T
    Oncotarget; 2015 Mar; 6(7):4733-44. PubMed ID: 25749381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells.
    Sharma BK; Kolhe R; Black SM; Keller JR; Mivechi NF; Satyanarayana A
    FASEB J; 2016 Jan; 30(1):262-75. PubMed ID: 26330493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in glycolytic/cholesterogenic gene expression in hepatocellular carcinoma.
    Jiang J; Zheng Q; Zhu W; Chen X; Lu H; Chen D; Zhang H; Shao M; Zhou L; Zheng S
    Aging (Albany NY); 2020 Jun; 12(11):10300-10316. PubMed ID: 32479426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of lncRNAs in the regulation of aerobic glycolysis in hepatocellular carcinoma: Main functions, regulatory mechanisms and potential therapeutic implications (Review).
    Huang Q; Liang Z; Huang Q; Li X; Xia J; Huang L; Huang LB; Ou C
    Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38666534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis.
    Luo X; Zheng E; Wei L; Zeng H; Qin H; Zhang X; Liao M; Chen L; Zhao L; Ruan XZ; Yang P; Chen Y
    Cell Death Dis; 2021 Mar; 12(4):328. PubMed ID: 33771982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA SNHG6 functions as a ceRNA to up-regulate c-Myc expression via sponging let-7c-5p in hepatocellular carcinoma.
    Chen S; Xie C; Hu X
    Biochem Biophys Res Commun; 2019 Nov; 519(4):901-908. PubMed ID: 31563323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-99a-5p inhibits glycolysis and induces cell apoptosis in cervical cancer by targeting RRAGD.
    Wang G; Lu Y; Di S; Xie M; Jing F; Dai X
    Oncol Lett; 2022 Jul; 24(1):228. PubMed ID: 35720506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic hsa_circ_0091581 promotes the malignancy of HCC cell through blocking miR-526b from degrading c-MYC mRNA.
    Wei X; Zheng W; Tian P; He Y; Liu H; Peng M; Li X; Liu X
    Cell Cycle; 2020 Apr; 19(7):817-824. PubMed ID: 32116112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.